| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003752445 |
| P356 | DOI | 10.1186/1755-7682-2-30 |
| P932 | PMC publication ID | 2771000 |
| P698 | PubMed publication ID | 19843330 |
| P5875 | ResearchGate publication ID | 38024314 |
| P50 | author | Shaheen Lakhan | Q30504782 |
| P2093 | author name string | Michael T Sapko | |
| P2860 | cites work | The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients | Q46432771 |
| Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). | Q46477623 | ||
| Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci | Q46908009 | ||
| Blood pressure level and outcomes in adults aged 65 and older with prior ischemic stroke | Q48422348 | ||
| Cause-specific mortality after first cerebral infarction: a population-based study. | Q51663871 | ||
| The high risk of stroke immediately after transient ischemic attack: a population-based study | Q57757011 | ||
| Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial | Q61456626 | ||
| The influence of nicardipine in patients with high risk of stroke | Q67894269 | ||
| Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group | Q69351154 | ||
| Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group | Q70641017 | ||
| Post-stroke antihypertensive treatment study. A preliminary result | Q70935260 | ||
| Blood pressure and stroke: an overview of published reviews | Q79843018 | ||
| [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial] | Q81006669 | ||
| The lowering of blood pressure after stroke | Q94032678 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack | Q28190600 | ||
| Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias | Q29616292 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke | Q30310949 | ||
| Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review | Q31016789 | ||
| Medications, comorbidities, and medical complications in stroke survivors: the CAReS study | Q34461536 | ||
| Telmisartan to prevent recurrent stroke and cardiovascular events | Q34596294 | ||
| Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group | Q36599327 | ||
| Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options | Q36815069 | ||
| Angiotensin-converting-enzyme inhibition in stable coronary artery disease | Q36915313 | ||
| Secondary prevention of stroke--results from the Southern Africa Stroke Prevention Initiative (SASPI) study. | Q37055296 | ||
| Use of ramipril in preventing stroke: double blind randomised trial | Q39524006 | ||
| The PROGRESS trial three years later: time for a balanced report of effectiveness | Q40243519 | ||
| J curve in antihypertensive therapy--does it exist? A personal point of view | Q40602843 | ||
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial | Q42542786 | ||
| Nicardipine in the prevention of cerebral infarction | Q43645370 | ||
| Control of hypertension and risk of stroke recurrence | Q43727438 | ||
| The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? | Q44279497 | ||
| The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors | Q44484610 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 30 | |
| P577 | publication date | 2009-10-20 | |
| P1433 | published in | International Archive of Medicine | Q18713043 |
| P1476 | title | Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis | |
| P478 | volume | 2 |
| Q92463060 | 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations |
| Q38267986 | An audit of the pharmacological management of ischaemic stroke patients in a metropolitan Australian hospital |
| Q89331052 | Antihypertensive drug therapy |
| Q35763418 | Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack |
| Q34066477 | Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data |
| Q57689006 | Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack |
| Q92126943 | Brain-heart interaction after acute ischemic stroke |
| Q88047472 | Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines |
| Q34362887 | Heart failure in acute ischemic stroke |
| Q38702269 | Hypertension and stroke: an appraisal of the evidence and implications for clinical management |
| Q35417852 | Hypertension as a risk factor: is it different in ischemic stroke and acute myocardial infarction comparative cross-sectional study? |
| Q37657027 | Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia |
| Q34053343 | Lowering of blood pressure for recurrent stroke prevention |
| Q37421197 | Nurse-Led Intervention to Improve Knowledge of Medications in Survivors of Stroke or Transient Ischemic Attack: A Cluster Randomized Controlled Trial. |
| Q26776296 | Personalized medicine and stroke prevention: where are we? |
| Q36279130 | Poor long-term blood pressure control after intracerebral hemorrhage |
| Q48444867 | Prestroke antihypertensive therapy: effect on the outcome. |
| Q43833530 | Secondary prophylaxis of stroke from a neurological perspective |
| Q50897785 | Severe stroke: patient profile and predictors of favorable outcome. |
| Q37964788 | Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence |
| Q33605427 | Stroke survivors' endorsement of a "stress belief model" of stroke prevention predicts control of risk factors for recurrent stroke |
| Q47613877 | The potential health and economic impact of improving stroke care standards for Australia |
| Q36510696 | Why is controlling blood pressure after stroke so difficult? |
Search more.